---
title: Mitogen-Activated Protein Kinase and Nuclear Hormone Receptor Crosstalk in
  Cancer Immunotherapy
date: '2023-09-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37686465/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230909181159&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: The three major MAP-kinase (MAPK) pathways, ERK1/2, p38 and JNK/SAPK,
  are upstream regulators of the nuclear "hormone" receptor superfamily (NHRSF), with
  a prime example given by the estrogen receptor in breast cancer. These ligand-activated
  transcription factors exert non-genomic and genomic functions, where they are either
  post-translationally modified by phosphorylation or directly interact with components
  of the MAPK pathways, events that govern their transcriptional activity towards
  ...
disable_comments: true
---
The three major MAP-kinase (MAPK) pathways, ERK1/2, p38 and JNK/SAPK, are upstream regulators of the nuclear "hormone" receptor superfamily (NHRSF), with a prime example given by the estrogen receptor in breast cancer. These ligand-activated transcription factors exert non-genomic and genomic functions, where they are either post-translationally modified by phosphorylation or directly interact with components of the MAPK pathways, events that govern their transcriptional activity towards ...